CN108771081A - Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof - Google Patents
Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof Download PDFInfo
- Publication number
- CN108771081A CN108771081A CN201810661130.8A CN201810661130A CN108771081A CN 108771081 A CN108771081 A CN 108771081A CN 201810661130 A CN201810661130 A CN 201810661130A CN 108771081 A CN108771081 A CN 108771081A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- weight
- haematococcus pluvialis
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020971 citrus fruits Nutrition 0.000 title claims abstract description 39
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 37
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 239000007787 solid Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 150000001875 compounds Chemical class 0.000 title claims description 23
- 239000000843 powder Substances 0.000 claims abstract description 72
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 239000000835 fiber Substances 0.000 claims abstract description 18
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000218218 Ficus <angiosperm> Species 0.000 claims abstract description 11
- 240000001439 Opuntia Species 0.000 claims abstract description 11
- 239000004376 Sucralose Substances 0.000 claims abstract description 11
- 239000000796 flavoring agent Substances 0.000 claims abstract description 11
- 235000019634 flavors Nutrition 0.000 claims abstract description 11
- 235000012680 lutein Nutrition 0.000 claims abstract description 11
- 239000001656 lutein Substances 0.000 claims abstract description 11
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 11
- 229960005375 lutein Drugs 0.000 claims abstract description 11
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 11
- 235000019408 sucralose Nutrition 0.000 claims abstract description 11
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 11
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 11
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 11
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 9
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 9
- 244000099147 Ananas comosus Species 0.000 claims abstract description 8
- 235000007119 Ananas comosus Nutrition 0.000 claims abstract description 8
- 244000175448 Citrus madurensis Species 0.000 claims abstract description 8
- 229920002752 Konjac Polymers 0.000 claims abstract description 8
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 8
- 239000002131 composite material Substances 0.000 claims abstract description 8
- 235000013312 flour Nutrition 0.000 claims abstract description 8
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 8
- 239000001259 polydextrose Substances 0.000 claims abstract description 8
- 229940035035 polydextrose Drugs 0.000 claims abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 4
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 4
- 239000011648 beta-carotene Substances 0.000 claims abstract description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 4
- 229960002747 betacarotene Drugs 0.000 claims abstract description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 241001672694 Citrus reticulata Species 0.000 claims 1
- 235000015205 orange juice Nutrition 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 235000012055 fruits and vegetables Nutrition 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 7
- 230000000968 intestinal effect Effects 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 36
- 241000700159 Rattus Species 0.000 description 20
- 210000002468 fat body Anatomy 0.000 description 19
- 208000008589 Obesity Diseases 0.000 description 13
- 235000020824 obesity Nutrition 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 210000001550 testis Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 241000207199 Citrus Species 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 244000088415 Raphanus sativus Species 0.000 description 4
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000001789 adipocyte Anatomy 0.000 description 4
- 230000003579 anti-obesity Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 108700022737 rat Fat1 Proteins 0.000 description 3
- 238000011552 rat model Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- GADIJPCDIWZEMB-BTNVMJJCSA-N (2r,3r)-2,3-dihydroxybutanedioate;hydron;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O.C[N+](C)(C)C[C@H](O)CC([O-])=O GADIJPCDIWZEMB-BTNVMJJCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000035611 feeding Effects 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940038580 oat bran Drugs 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical class OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 101710089165 Protein white Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention discloses a kind of complex solid plant beverage of weight-reducing and preparation method thereof.The complex solid plant beverage includes citrus fruit fibres, apple fiber, Semen Tritici aestivi fiber, konjaku flour, fruits and vegetables composite ferment powder, orange fruit powder, polydextrose, green cumquat powder, pineapple powder, citric acid, beta carotene, Opuntia ficus' fruit powder, orange blossom powder, haematococcus pluvialis, L-carnitine-L-tartrate, conjugated linoleic acid glyceride, radix polygonati officinalis powder, lutein, Sucralose, food flavor.The present invention does not injure gastrointestinal tract while capable of losing weight, and can improve human-body sub-health, improves intestinal flora environment, is beneficial to intestinal movement, builds up health.
Description
Technical field
The present invention relates to plant beverage technical fields, and in particular to a kind of haematococcus pluvialis citrus fruit fibres of weight-reducing are compound
Solid beverage and preparation method thereof.
Background technology
With the variation of resident living mode and dietary structure in recent years, fat illness rate is in rapid increase trend, fertilizer
It is fat to have become one of the serious public health problem faced.Obesity, diabetes, hypertension and angiocardiopathy have become prestige
Coerce the greatest danger factor of health of people.Wherein, fat is mainly luring for the slow disease such as diabetes, hypertension, angiocardiopathy again
One of because, it is seen that problem of obesity has risen to as the main problem of relationship resident's publilc health.
Have antiobesity action on the market at present is drug or health food mostly, can add various chemical substances to reach
Mode to control appetite, the consumption energy such as diarrhea loses weight, and long term usage can cause gastrointestinal bacterial flora disorder, functional disturbance, right
Body has very big damage.
Such as:CN201710050144.1 discloses a kind of meal replacement powder with fat reducing weight losing function, including following component:Essence
10-20 parts of oat bran powder processed;20-30 parts of wheat bran powder;3-6 parts of palm oil powder;10-20 parts of PURE WHEY;Aqueous soluble dietary
5-10 parts of fiber;0.05-0.5 parts of sweetener;0.1-0.5 parts of fragrance, after all raw materials are poured into batch mixer mixing 10-20 minutes
Spray drying is to get the meal replacement powder with fat reducing weight losing function.The refined oat bran powder of pure Physical Processing of the present invention is not only substantially
Raw starch content is reduced, feature low in calories is made it have, and increases the nutrition of vitamin, minerals and protein
Density, and the oat beta glucan rich in natural structure.It is different from oat beta glucan prepared by biological enzymolysis technology, refine swallow
Oat beta glucan remains natural macromolecular structure in wheat bran.It is reached in natural structure oat beta glucan of the human body per canteen
When to 3 grams or more, in human gastrointestinal tract that the food for forming very high viscosity is rotten, this not only adds human body satieties, more attach most importance to
What is wanted is the absorption for substantially slowing down and reducing sugar and fat, so that human body postprandial blood sugar is effectively controlled, plays low glycemic
The important function of diet.Physiologic theory shows the secretion of elevated blood glucose levels stimulation insulin, and insulin, which has, promotes fat to close
At effect, to fat reducing, weight-reducing it is unfavorable.Therefore, people to lose weight needs, by low glycemic diet, to reduce postprandial insulin levels,
To promote the decomposition of fat, the purpose of fat reducing and weight-reducing is realized.
CN201210133677.3 discloses a kind of fat-reducing nutrient stick and its from Preparation Method, and formula composition is soybean separation protein
White swelling granular 20%~50%;Maltitol liquor 15%~30%;Water-soluble dietary fiber 8%~25%;Condensed whey egg
White 1%~8%;Glycerine 1%~8%;Isin glue collagen 1%~8%;Phytosterol 1%~2%;Quick-frozen blueberry grain 1%~
4%;Arabic gum 0.5%~3%;Casein sodium 0.5%~2%;Multi-vitamins 0.03%~0.12%.The invention carries
A kind of nutrition-balanced diet food has been supplied, following component is contained:Soybean protein isolate swelling granular;Maltitol liquor;It is water-soluble
Property dietary fiber;Whey protein concentrate;Glycerine;Isin glue collagen;Phytosterol;Quick-frozen blueberry grain;Arabic gum;Caseinic acid
Sodium;Multi-vitamins.The fat-reducing nutrient stick is in good taste, and protein content is high, there is enhancing satiety can supplement protein again, simultaneously
It is added to the functional food ingredients such as Isin glue collagen, phytosterol and multi-vitamins etc. again, so that consumer is reached health and subtracts
The purpose of fertilizer.
Invention content
In view of the technical drawbacks of the prior art, it is an object of the present invention to provide a kind of rain of weight-reducing to give birth to red ball
Algae citrus fruit fibres compound solid beverage and preparation method thereof.
The technical solution adopted to achieve the purpose of the present invention is:
A kind of haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, by weight, including:
300-800 parts of citrus fruit fibres, 300-800 parts of apple fiber, 300-800 parts of Semen Tritici aestivi fiber, konjaku flour 500-1500
Part, 1000-2500 parts of fruits and vegetables composite ferment powder, 300-800 parts of orange fruit powder, 200-500 parts of polydextrose, green cumquat powder 100-
300 parts, 100-300 parts of pineapple powder, 100-300 parts of citric acid, 100-300 parts of beta carotene, Opuntia ficus' fruit powder 5-15
Part, 5-15 parts of orange blossom powder (French citrus polyphenol), 5-15 parts of haematococcus pluvialis, 30-80 parts of L-carnitine-L-tartrate, conjugation
30-80 parts of glyceryl linoleate, 20-80 parts of radix polygonati officinalis powder, 5-15 parts of lutein (10%), 5-20 parts of Sucralose, food flavor
20-48 parts of (orange taste).
A kind of preparation method of the haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, includes the following steps:
Load weighted Opuntia ficus' fruit powder, orange blossom powder, haematococcus pluvialis, L-carnitine-L-tartrate, conjugation is sub-
Olein, radix polygonati officinalis powder, lutein, Sucralose, food flavor mix 60 minutes, remaining load weighted raw material is then added
60 minutes are remixed to get finished product.
In the prescription of the present invention, l-cn is a kind of amino acid promoting adipose conversion as energy, nontoxic to human body
Side effect, particularly suitable people's cooperation does aerobic exercise and carrys out fat reducing, while reducing the triglyceride in blood and cholesterol levels,
Also fat extra in incendivity body can lose weight as energy, reduce the content of body fat, have antiobesity action;
Conjugated linoleic acid glyceride is the pure natural active factor of the health type of latest find in the world, can play alleviate fatty liver,
The effect of weight-reducing, and hyperlipidemia, the state of an illness of diabetic can be controlled;Haematococcus pluvialis is acknowledged as producing day in nature
The best biology of right astaxanthin, is rich in astaxanthin, and astaxanthin is strongest natural in nature, has anti-aging,
Immunity is improved, has inhibiting effect to inflammation, and the good results are evident;Haematococcus pluvialis is arranged in pairs or groups radix polygonati officinalis powder, lutein simultaneously, is used
To build up resistance, eliminate the inflammation of parts of body, alleviation sub-health state;This product is with the original with effect of weight reducing
When material, arrange in pairs or groups various raw fiber food raw materials and fruit powder:Citrus fruit fibres, apple fiber part, Semen Tritici aestivi fiber, konjaku flour part, fruits and vegetables
Composite ferment powder, orange fruit powder, polydextrose, green cumquat powder, pineapple powder, beta carotene, Opuntia ficus' fruit powder, orange blossom
Powder improves the bad habit of constipation, achievees the purpose that defaecation, add simultaneously for improving gastrointestinal bacterial flora and increasing intestines peristalsis
Add corrigent citric acid, Sucralose, food flavor, is this product sweet and sour taste, convenient for being esthetically acceptable to the consumers.It is former used in this product
Material be natural food material source, it is without any side effects, be suitble to long-term consumption, for improve with hypoimmunity, constipation,
Inferior health caused by fat, various inflammation.
The present invention does not injure gastrointestinal tract while capable of losing weight, and can improve human-body sub-health, improves intestinal flora environment, has
Beneficial to intestinal movement, build up health.
Specific implementation mode
Embodiment 1
The haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, by weight, including:
300 parts of citrus fruit fibres, 300 parts of apple fiber, 300 parts of Semen Tritici aestivi fiber, 500 parts of konjaku flour, fruits and vegetables composite ferment powder
1000 parts, 300 parts of orange fruit powder, 200 parts of polydextrose, green 100 parts of cumquat powder, 100 parts of pineapple powder, 100 parts of citric acid, β-Hu
It is 100 parts of radish element, 5-15 parts of Opuntia ficus' fruit powder, 5 parts of orange blossom powder (French citrus polyphenol), 5 parts of haematococcus pluvialis, left-handed
30 parts of carnitine tartrate, 30 parts of conjugated linoleic acid glyceride, 20 parts of radix polygonati officinalis powder, (10%) 5 part of lutein, 5 parts of Sucralose,
20 parts of food flavor (orange taste).
Embodiment 2
The haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, by weight, including:
800 parts of citrus fruit fibres, 800 parts of apple fiber, 800 parts of Semen Tritici aestivi fiber, 1500 parts of konjaku flour, fruits and vegetables composite ferment powder
2500 parts, 800 parts of orange fruit powder, 500 parts of polydextrose, green 300 parts of cumquat powder, 300 parts of pineapple powder, 300 parts of citric acid, β-Hu
It is 300 parts of radish element, 15 parts of Opuntia ficus' fruit powder, 15 parts of orange blossom powder (French citrus polyphenol), 15 parts of haematococcus pluvialis, left-handed
80 parts of carnitine tartrate, 80 parts of conjugated linoleic acid glyceride, 80 parts of radix polygonati officinalis powder, (10%) 15 part of lutein, Sucralose 20
Part, 48 parts of food flavor (orange taste).
Embodiment 3
The haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, by weight, including:
550 parts of citrus fruit fibres, 550 parts of apple fiber, 550 parts of Semen Tritici aestivi fiber, 1000 parts of konjaku flour, fruits and vegetables composite ferment powder
1750 parts, 550 parts of orange fruit powder, 350 parts of polydextrose, green 200 parts of cumquat powder, 200 parts of pineapple powder, 200 parts of citric acid, β-Hu
200 parts of radish element, 10 parts of Opuntia ficus' fruit powder, orange blossom powder (10 parts of French citrus polyphenol, 10 parts of haematococcus pluvialis, left-handed meat
40 parts of alkali tartrate, 40 parts of conjugated linoleic acid glyceride, 50 parts of radix polygonati officinalis powder, (10%) 10 part of lutein, 13 parts of Sucralose,
34 parts of food flavor (orange taste).
Embodiment 4
The haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, by weight, including:
500 parts of citrus fruit fibres, 500 parts of apple fiber, 500 parts of Semen Tritici aestivi fiber, 1000 parts of konjaku flour, fruits and vegetables composite ferment powder
1500 parts, 500 parts of orange fruit powder, 300 parts of polydextrose, green 200 parts of cumquat powder, 200 parts of pineapple powder, 200 parts of citric acid, β-Hu
200 parts of radish element, 10 parts of Opuntia ficus' fruit powder, orange blossom powder (10 parts of French citrus polyphenol, 10 parts of haematococcus pluvialis, left-handed meat
50 parts of alkali tartrate, 50 parts of conjugated linoleic acid glyceride, 60 parts of radix polygonati officinalis powder, (10%) 10 part of lutein, 15 parts of Sucralose,
28 parts of food flavor (orange taste).
The preparation method of the haematococcus pluvialis citrus fruit fibres compound solid beverage of the weight-reducing of the various embodiments described above, including with
Lower step:
By Opuntia ficus' fruit powder of 80 mesh of load weighted mistake sieve, orange blossom powder, haematococcus pluvialis, L-Carnitine tartrate
Salt, conjugated linoleic acid glyceride, radix polygonati officinalis powder, lutein, Sucralose, food flavor mix 60 minutes, remaining is then added and claims
The raw material of 80 mesh of measured mistake sieve remixes 60 minutes to get finished product, then bag distribution packaging.
Pharmacy test:
Animal experiment
1. materials and methods
1.1 animal:
Cleaning grade male SD rat 60,6~8 week old, 160~200g of weight are provided by Zhejiang Province's Experimental Animal Center,
Animal credit number SCXK (Zhejiang) 2014-0001.20~25 DEG C of feeding environment temperature, humidity 40%~60%, 12h/12h light
Bright/dark condition.
1.2 drugs and reagent:
Experiment is with sample using the haematococcus pluvialis citrus fruit fibres compound solid beverage prepared by embodiment 3;Orlistat
(Haizheng Medicine Stock Co., Ltd., Zhejiang Prov, 15051901);High glucose and high fat feed (Zhejiang Province's Experimental Animal Center);ELISA is examined
Test agent box (is purchased from the Shanghai bio tech ltd Yuan Ye, E20160301A);Eosin stain, haematoxylin dye liquor (Nanjing
Build up Science and Technology Ltd., 20151216).Healthy adult female BAl BIc/C mice, 18~22g of weight, Huaxi Medical Univ's examination
It tests animal center and (quality certification number is provided:Guan Zhi 64 is moved in fact in river).
1.3 method
1.3.1 the preparation and grouping of obese model:60 male SD rat adaptable feds are after 1 week, wherein 50 feedings
High glucose and high fat feed prepares DIO models, and another 10 are only used as normal group, give chow diet.During modeling, each group rat freely drinks
Water is ingested.It is more than the 10% of normal rats weight to be used as obesity standard after modeling 8 weeks, using weight, chooses 40 modelings successfully
DIO rats, continue to give high glucose and high fat feed.It is randomly divided into model group according to weight, orlistat group (32.4mg/kg),
Haematococcus pluvialis citrus fruit fibres compound solid beverage high dose group (200mg/kg), haematococcus pluvialis citrus fruit fibres complex solid drink
Material low dose group (100mg/kg), every group 10.Gavage gives relative medicine respectively, continuous 13 weeks, administered volume 10mL/kg,
0.4% carboxymethylcellulose sodium solution of model group and normal group gavage equivalent.
1.3.2 weight, food ration, amount of drinking water and Lee's indexes:Experiment terminates first 1 day, measures each group Rat 24 h drink
Water, food ration.After the last administration, weight, body length (length of nose to anus) are measured, Lee's indexes Index is calculated.It calculates
Formula is as follows:Lee's indexes=(weight × 1000) ^ (1/3)/body length (cm).
1.3.3 liver body when fat body ratio:After rat is put to death, separation liver, kidney week and testis week fat are simultaneously weighed, and liver body is calculated
When fat body ratio.Calculation formula is as follows:Liver body ratio=liver mass (mg)/weight (g) × 100%;Fat body ratio=(kidney week or testis
Week) fat mass (mg)/weight (g) × 100%;Total fat body ratio=(kidney week+testis week) fat mass (mg)/weight (g) ×
100%.
1.3.4 the comparison of fatty pathological section:Take the same position of testis week fat, 10% formalin fixes, ethanol dehydration,
Dimethylbenzene is transparent, paraffin embedding, be sliced, 5 μm of paraffin sections, microscopically observation after HE dyeing is made.
1.3.5 statistical procedures:Experimental data is indicated using x ± s, and statistical analysis is carried out using 16.0 softwares of SPSS,
Statistical method is one-way analysis of variance (One-wayANOVA).P < 0.05 or P < 0.01 indicate statistically significant.
2 results
The influence of 2.1 pairs of rat body weights, food ration, amount of drinking water and Lee's indexes:Compared with normal group, rat model body
Weight, Lee's indexes increase (P < 0.01);Compared with model group, 2 dosage of haematococcus pluvialis citrus fruit fibres compound solid beverage
Group rat body weight, Lee's indexes are decreased obviously (P < 0.05);And food ration, amount of drinking water is shown in Table 1 then without significant change, right
The influence (x ± s, n=10) of DIO rat body weights, food ration, amount of drinking water and Lee's indexes.
Table 1
Note:The * P < 0.01 compared with normal group;The * * P < 0.05 compared with model group, * * * P < 0.01.
2.2 pairs of rat fat bodies when liver body than influence:Compared with normal group, rat model kidney fat body ratio, testis fat body ratio,
Total fat body when liver body
Than raising (P < 0.01);Compared with model group, 2 dosage groups of haematococcus pluvialis citrus fruit fibres compound solid beverage
Rat renal fat body ratio, testis fat body ratio are decreased obviously (P < 0.05);The total fat body of high dose group is than declining;And 2 dosage group liver bodies
Than having no significant change, be shown in Table 2, to DIO rat fat body when liver body than influence (x ± s, n=10);
Table 2
Note:The * P < 0.01 compared with normal group;The * * P < 0.05 compared with model group, * * * P < 0.01
The influence of 2.3 pairs of rat testis week adipose tissue pathology variations:HE dyeing displays, after being administered 13 weeks, normal rat fat
Fat cell arrangement is close, and cell edges are clear;Rat model adipocyte volume significantly increases (P < compared to normal group
0.01), and cell edges are fuzzy, and cellular morphology is irregular, imperfect.Compared with model group, 2 dosage groups can be in various degree
Reduction adipocyte volume (P < 0.01), significantly improve cellular morphology.
3 analyses
This experiment continuously feeds modeling in 8 weeks, the bad life not saved close to mankind's diet using high glucose and high fat feed
Custom, while meeting theory of traditional Chinese medical science to fat understanding.Obesity is mainly manifested in body fat accumulation excessively, and wherein testis week
The content of fat and perirenal fat accounts for the certain proportion of total fat mass, thus commonly use this 2 indexs and they and it is with weight
Ratio (fat body ratio) reflects Obesity;Meanwhile high glucose and high fat feed can lead to the accumulation of liver fat, so as to cause liver
The increase of coefficient.And Lee's indexes are equivalent to the body-mass index (BMI) of people, are to evaluate having for adult rat obese degree
Imitate index.The indexs synchronizations such as rat body weight, Lee's indexes, fat coefficient, liver coefficient are compared in this experiment, are more fully commented
Valence weight-reducing drug effect.
The experimental results showed that compared with normal group, the weight of model group rats, Lee's indexes, kidney fat body ratio, testis fat body
When total fat body ratio significantly rises, and prompts DIO obese model modelings success;Give haematococcus pluvialis citrus fruit fibres complex solid drink
After expecting 13 weeks, the weight of haematococcus pluvialis citrus fruit fibres 2 dosage group rats of compound solid beverage, Lee's indexes, kidney fat body
It is remarkably decreased than than, testis fat body;The total fat body of high dose group rat is than significantly reducing, haematococcus pluvialis citrus fruit fibres complex solid
Beverage has the function of weight-reducing to DIO rats.Compared with model group, 2 agent of haematococcus pluvialis citrus fruit fibres compound solid beverage
The food ration of amount group rat, the equal no significant difference of amount of drinking water prompt haematococcus pluvialis citrus fruit fibres compound solid beverage big to DIO
The antiobesity action of mouse is generated by Anorectic effect Alcohol.
In conclusion haematococcus pluvialis citrus fruit fibres compound solid beverage DIO obese rats have certain antiobesity action,
Mechanism of action may be related at fat differentiation, the reduction size of adipocyte to inhibition.
To haematococcus pluvialis citrus fruit fibres compound solid beverage prepared by other embodiments 1,2,4, above-mentioned side is equally used
Method is tested, and has equally been achieved the effect that above-mentioned.
Clinical test:
1) general information:120 case clinical observations of the present inventor couple, wherein man 61, female 59;Age minimum 18
It is year, 60 years old maximum;Simple obesity 37, obesity merging blood fat and blood pressure is 49 high, hyperlipidemia, hypoimmunity 30, other 4
(including fat fatiguability person, obesity are susceptible to suffer from various inflammation etc. simultaneously).
2) therapy:Twice for each person every day, each 6g (beverage prepared by embodiment 3).
3) efficacy assessment standard:
It cures:Clinical symptoms completely disappear, and restore normal type.
Effectively:A weight loss part, remaining symptom disappear
In vain:Symptom, sign are without significant change.
4) treatment results:Treatment results such as the following table 3.
Total case | It cures | Effectively | In vain | It is efficient |
120 | 86 | 28 | 6 | 95% |
Table 3
120 are equally used to haematococcus pluvialis citrus fruit fibres compound solid beverage prepared by other embodiments 1,2,4
Case carries out clinical test, and effective percentage respectively reaches 90%, 93%, 91%.
5) typical clinical case:
1, Zhang, man, 21 years old, simple obesity in 2016, after taking this product 30 days, weight recovery to normal level.
2, Qi, female, 41 years old, Hyperlipidemia in 2017, fat, after taking this product 28 days, blood fat was normal, and weight loss is extremely
Normal level.
3, Zhang, man, 49 years old, blood fat and blood pressure height, obesity, immunity degradation in 2017, after taking this product 30 days, recovery from illness.
4, Lee, man, 59 years old, blood fat and blood pressure height, obesity, immunity degradation in 2016, after taking this product 35 days, fully recovered
5, money, female, 40 years old, blood fat and blood pressure height, obesity, immunity degradation in 2015, after taking this product 33 days, fully recovered
6, Wei, man, 35 years old, blood fat and blood pressure height, obesity, immunity degradation in 2016, after taking this product 30 days, recovery from illness.
Claims (2)
1. the haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing, which is characterized in that by weight, including:
300-800 parts of citrus fruit fibres, 300-800 parts of apple fiber, 300-800 parts of Semen Tritici aestivi fiber, 500-1500 parts of konjaku flour, fruit
1000-2500 parts of vegetable composite ferment powder, 300-800 parts of orange fruit powder, 200-500 parts of polydextrose, green cumquat powder 100-300
Part, 100-300 parts of pineapple powder, 100-300 parts of citric acid, 100-300 parts of beta carotene, 5-15 parts of Opuntia ficus' fruit powder, mandarin orange
5-15 parts of orange juice powder, 5-15 parts of haematococcus pluvialis, 30-80 parts of L-carnitine-L-tartrate, conjugated linoleic acid glyceride 30-80
Part, 20-80 parts of radix polygonati officinalis powder, 5-15 parts of lutein, 5-20 parts of Sucralose, 20-48 parts of food flavor.
2. the preparation method of the haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing as described in claim 1, feature
It is, includes the following steps:
By load weighted Opuntia ficus' fruit powder, orange blossom powder, haematococcus pluvialis, L-carnitine-L-tartrate, conjugated linoleic acid
Glyceride, radix polygonati officinalis powder, lutein, Sucralose, food flavor mix 60 minutes, remaining load weighted raw material is then added and mixes again
60 minutes are closed to get finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810661130.8A CN108771081A (en) | 2018-06-25 | 2018-06-25 | Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810661130.8A CN108771081A (en) | 2018-06-25 | 2018-06-25 | Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108771081A true CN108771081A (en) | 2018-11-09 |
Family
ID=64026327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810661130.8A Pending CN108771081A (en) | 2018-06-25 | 2018-06-25 | Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108771081A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115989867A (en) * | 2022-12-07 | 2023-04-21 | 广东金骏康生物技术有限公司 | Citrus composition for losing weight and preparation method and application thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404827A (en) * | 2013-07-08 | 2013-11-27 | 北京康比特体育科技股份有限公司 | Seasoning capable of loosing weight |
CN105995976A (en) * | 2016-05-19 | 2016-10-12 | 厦门元之道生物科技有限公司 | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof |
CN106174182A (en) * | 2016-07-12 | 2016-12-07 | 上海广得利保健食品有限公司 | A kind of comprehensive vegetables and fruits composite powder |
CN106509126A (en) * | 2016-10-25 | 2017-03-22 | 郑州福润德食品有限公司 | Solid drink having weight losing and body slimming functions |
CN107307406A (en) * | 2017-08-01 | 2017-11-03 | 王海军 | A kind of weight-reducing tablet and preparation method thereof |
-
2018
- 2018-06-25 CN CN201810661130.8A patent/CN108771081A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404827A (en) * | 2013-07-08 | 2013-11-27 | 北京康比特体育科技股份有限公司 | Seasoning capable of loosing weight |
CN105995976A (en) * | 2016-05-19 | 2016-10-12 | 厦门元之道生物科技有限公司 | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof |
CN106174182A (en) * | 2016-07-12 | 2016-12-07 | 上海广得利保健食品有限公司 | A kind of comprehensive vegetables and fruits composite powder |
CN106509126A (en) * | 2016-10-25 | 2017-03-22 | 郑州福润德食品有限公司 | Solid drink having weight losing and body slimming functions |
CN107307406A (en) * | 2017-08-01 | 2017-11-03 | 王海军 | A kind of weight-reducing tablet and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115989867A (en) * | 2022-12-07 | 2023-04-21 | 广东金骏康生物技术有限公司 | Citrus composition for losing weight and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109170459A (en) | A kind of albumen cereal fruit-vegetable powder solid beverage and preparation method | |
CN101496580B (en) | Special diet and foodstuffs formula containing small peptide for diabetic | |
CN103229963B (en) | Coarse cereal food subjected to treatment of germination and preparation method of coarse cereal food | |
CN102077936B (en) | Special sea dietary food for diabetics | |
CN101606704B (en) | Dietary fiber food with various functional actions | |
CN106942731A (en) | A kind of nutrient powder eaten suitable for the three high patients and preparation method thereof | |
CN102524659A (en) | Grain formula with nutrition and health care functions | |
CN102113648A (en) | Special dietary noodle applicable to people suffering from 'five-high' metabolic syndrome and preparation method thereof | |
CN103005261B (en) | Diet supplement capable of restraining diabetic patient's blood sugar level from increasing after meal | |
CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
CN103211162A (en) | Fermented coarse cereal food and preparation method thereof | |
CN101473953A (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN102526479B (en) | Health-care medicine formula with functions of enhancing immunity and lowering blood sugar | |
CN102125212B (en) | Health-care weight loss product and preparation method thereof | |
CN105211687A (en) | A kind of composition and method of making the same and purposes | |
WO2011060585A1 (en) | Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof | |
CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
CN106418501A (en) | Healthcare food with weight reducing function | |
CN102613453B (en) | Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application | |
CN113712199A (en) | Weight-losing leaf-eating grass meal-replacing food | |
CN105943958A (en) | Inonotus obliquus composite solid particles for treating gout and preparing method thereof | |
CN101053392A (en) | Soluble dietary fiber of konjak | |
CN108771081A (en) | Haematococcus pluvialis citrus fruit fibres compound solid beverage of weight-reducing and preparation method thereof | |
CN102860505A (en) | Korean medicinal healthcare food composition with effect of assisting in protecting gastric mucosa, and preparation method and use thereof | |
CN101283761A (en) | Smallanthus sonchifolius fruit extract and extracting method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181214 Address after: 102200 No. 79 Changcui Road, Nanshao Town, Changping District, Beijing Applicant after: BEIJING BEIFRED HEALTH TECHNOLOGY Co.,Ltd. Address before: 301700 No. 19 Yunjing Road, Shangmatai Town, Wuqing District, Tianjin Applicant before: TIANJIN FEIRUIDE BIOTECHNOLOGY Co.,Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181109 |